
Developing a vaccine for the zombie drug xylazine Scripps Research chemical biologists design an early proof-of-concept vaccine that could lead to the first effective treatment of xylazine overdose in people.
April 03, 2024
LA JOLLA, CA Xylazine is an FDA-approved sedative and pain reliever for use in animals, but it has severe adverse effects when used in humans. It is now illicitly being added to opioids, like fentanyl and heroin, as well as cocaine leading to a sharp rise in overdose deaths.
Now, Scripps Research chemical biologists have developed a vaccine to block the effects of xylazine's toxicity. The vaccine works by training the immune system to attack the drug, which is described in a new paper published in Chemical Communications on April 1, 2024.
We demonstrated that a vaccine can reverse the symptoms of a xylazine overdose in rodents, says study senior author Kim D. Janda, PhD, the Ely R. Callaway, Jr. Professor of Chemistry at Scripps Research. There is currently no remedy for xylazine poisoning other than supportive care, thus, we believe our research efforts and the data we have provided will pave the way for an effective treatment in humans.
The rapid increase in lethal drug overdoses attributed to xylazine combined with fentanyl prompted the White House Office of National Drug Control Policy to declare this combination an emerging threat to the United States. Xylazine intoxication presents similarly to opioid overdose, causing respiratory and central nervous system depression, and it can heighten the effects of opioids. However, naloxone typically administered to reverse the effects of opioids does not tackle the impact of xylazine, highlighting the need for effective measures to treat acute toxicity caused by xylazine.
Researchers suspect xylazine works by reducing blood flow to the brain, among other areas of the body. The drug also causes non-healing skin lesions and wounds, often located on the forearms and lower legs, that can require amputation in some cases giving it the nickname zombie drug.
Although no treatment currently exists, targeted vaccines may offer a solution. Vaccines nudge the immune system to create antibodies to fend off invaders. Antibodies can target viruses, bacteria and toxins. However, sometimes molecules are too small to initiate an immune response, as is the case with xylazine. So, to circumvent this problem, the researchers created a vaccine using a design principle that Janda pioneered, which relies on pairing the drug molecule (called a hapten) with a larger carrier molecule (a protein) and an adjuvant.
In this study, the scientists combined a xylazine hapten with multiple different protein types, to see which combination would create a robust immune response against xylazine. The team tested three vaccine formulations (termed TT, KLH and CRM197, based on the protein involved) to see which vaccine cocktail could help rodents after being challenged with xylazine. One of the three vaccines (TT) significantly increased movement in mice given xylazine after 10 minutes, while two of the three vaccines (TT and KLH) led to an improvement in breathing.
The scientists also examined how these vaccines would limit xylazine blood brain barrier, (BBB) permeation, a filtering mechanism that scrutinizes drug penetration. When xylazine was injected, it immediately crossed into the brain to bind with receptors. Antibodies typically cannot navigate the BBB; however, two of the three vaccines (TT and KLH) showed a strong ability to stop xylazine from reaching its receptors in the brain, limiting its detrimental effects.
A provisional patent has been filed on the research. In the future, his team will build off this work to create a bifunctional antibody that will reverse both fentanyl and xylazine's toxicity simultaneously, something that naloxone cannot do.
A monoclonal antibody treatment could be given in tandem with the vaccine to provide both immediate and long-term protection from both opioid substance use disorders as well as opioid-xylazine overdoses, says Janda. This strategy could make a significant impact on the opioid epidemic.
Evaluation of a Hapten Conjugate Vaccine Against the Zombie Drug' Xylazine was co-authored by Mingliang Lin, Lisa M. Eubanks, Bin Zhou, and Kim D. Janda, all of Scripps Research.
Funding for the study was provided by the Shadek family and Pearson Foundation.
Chemistry Janda, Kim
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
18/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
18/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
18/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
18/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
18/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , er...
18/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
18/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
18/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
18/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
18/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
18/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
18/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
18/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
18/11/2026
SMPTE, the home for media professionals, technologists and engineers, today announced the publication of an engineering report with the summarized results of an...
18/11/2026
Brendan O'Connor joins six disabled job seekers as they navigate the barriers of finding work and challenge perceptions of disability in the workplace
Begi...
18/11/2026
Poison Ink begins Friday 20 November 2026 on RT Listen and RT Radio 1
Listen ...
18/11/2026
RT Choice Music Prize
In association with IMRO and IRMA
2027 KEY DATES
Irish Album of the Year 2026 Shortlist 18th January
Irish Artist of the Year 2026 ...
18/11/2026
New NVIDIA RTX Spark compact desktops from ASUS, Dell and MSI are available today, bringing local AI agents, image and video generation, and model fine-tuning t...
17/11/2026
Fabric Insights and Fonn Group have announced a partnership to connect editorial...
17/11/2026
The National Association of Black Journalists is offering up a Thanksgiving Eve treat on Wednesday, Nov. 25, in the form of a live streaming event featuring for...
17/11/2026
Bridge Technologies has announced that its VB440 production probe now supports both monitoring and signal generation for Apple ProRes video streams. The additio...
17/11/2026
Canon U.S.A., Inc. recently welcomed 21 Jericho High School students to its Melv...
17/11/2026
Spectrum News has deployed the Amagi platform to support its live news operations. Amagi says the platform lets Spectrum News streamline newsroom workflows, red...
17/11/2026
Microsoft has expanded its use of Haivision's live video contribution ecosys...
17/11/2026
Setanta Sports has deployed Ateme's TITAN Live platform to support its OTT video delivery operations. Ateme's transcoding technology is integrated into ...
17/11/2026
Media Links has joined the KAIROS Alliance Partner program for Panasonic's KAIROS IT/IP live video production platform. The company completed interoperabili...
17/11/2026
Behind The Mic provides a roundup of recent news regarding on-air talent, including new deals, departures, and assignments compiled from press releases and repo...
17/11/2026
In live sports and in life, things go by in the blink of an eye. Savoring the mo...
17/11/2026
Satellite operators are adding a new generation of low-Earth-orbit (LEO) network...
17/11/2026
Clear-Com has delivered five customized test systems for electromagnetic securit...
17/11/2026
Stephen Arnold Music (SAM) has created the sonic identity for WTGL, the women's team golf league from TMRW Sports, created in partnership with the LPGA and ...
17/11/2026
The Professional Audio Manufacturers Alliance (PAMA) has introduced Give Sound a Voice, an initiative aimed at raising awareness of the value of sound among the...
17/11/2026
Fanatics Studios, the sports entertainment joint venture between Fanatics and OBB, has named Jamal Henderson its first President of Film & TV, announced Michael...
17/11/2026
The NFL's Thanksgiving Week games will feature halftime performances by U2, ...
17/11/2026
FanSided, a Minute brand with more than 250 fan communities, has launched a redesigned mobile app that combines team news, analysis, live game coverage, stats a...
17/11/2026
Major League Volleyball (MLV), the longest-running indoor professional volleybal...
17/11/2026
Prime Video will present a 15-hour slate of live sports on Black Friday, Nov. 27...
17/11/2026
Catherine Dior was more than a muse. A Resistance fighter, a survivor of deporta...
17/11/2026
Multiband dynamics plug-in boasts FT1 integration
Freqport's latest plug-in combines multiband upward and downward dynamics with the company's renow...
17/11/2026
Hi-fi experts launch two pro-audio models
Berlin-based hi-fi experts Teufel Audio have recently branched out into the pro-audio world with their first pairs...
17/11/2026
A year of ComposerCloud+ for $99
EastWest's annual Black Friday Sale is already live, and new users are being offered one year of the all-encompassing C...
17/11/2026
Pick your favourite gear from 2026
The annual SOS Awards are now underway, and as always, we're asking readers to help us choose the best pro-audio rele...
17/11/2026
As part of an ongoing series production program for a German automaker, production capacity has been increased at SGL Carbon's Austrian site in Ried im Innk...
17/11/2026
eds3_5_jq(document).ready(function($) { $(#eds_sliderM519).chameleonSlider_2_1({...
17/11/2026
Signiant has acquired the media intelligence technology, Ceivo, developed by Burnlab with founder Aaron Sloman joining the company as Vice President, Product Ma...
17/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
17/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
17/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
17/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...